A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer (vol 353, pg 2747, 2005)

被引：0
|
作者：
Wardley, A
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2200 / 2200
页数：1
相关论文
共 50 条
  • [1] A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
    Thürlimann, B
    Keshaviah, A
    Coates, AS
    Mouridsen, H
    Mauriac, L
    Forbes, JF
    Paridaens, R
    Castiglione-Gertsch, M
    Gelber, RD
    Rabaglio, M
    Smith, I
    Wardly, A
    Price, KN
    Goldhirsch, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (26): : 2747 - 2757
  • [2] Letrozole reduces spread of early breast cancer after tamoxifen therapy in postmenopausal women
    不详
    [J]. ONCOLOGY-NEW YORK, 2004, 18 (09): : 1156 - +
  • [3] Letrozole or tamoxifen in early breast cancer
    Erban, JK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14): : 1529 - 1529
  • [4] Effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole
    Safra, T.
    Molho, R. Bernstein
    Stephansky, I.
    Yaal-Hahoshen, N.
    Inbar, M.
    Ackerstein, A.
    Geffen, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Breast cancer of an accessory nipple (vol 353, pg 1835, 2005)
    Gendler, LS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05): : 537 - 537
  • [6] Zoledronic acid protective effect on bone loss in postmenopausal women with early breast cancer switched from tamoxifen to letrozole
    Safra, T.
    Molho, R. Bernstein
    Stephansky, I.
    Yaal-Hahoshen, N.
    Inbar, M.
    Ackerstein, A.
    Geffen, D.
    [J]. BREAST, 2009, 18 : S60 - S60
  • [7] A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
    Goss, PE
    Ingle, JN
    Martino, S
    Robert, NJ
    Muss, HB
    Piccart, MJ
    Castiglione, M
    Tu, D
    Shepherd, LE
    Pritchard, KI
    Livingston, RB
    Davidson, NE
    Norton, L
    Perez, EA
    Abrams, JS
    Therasse, P
    Palmer, MJ
    Pater, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19): : 1793 - 1802
  • [8] Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer
    Dowsett, M
    Pfister, C
    Johnston, SRD
    Miles, DW
    Houston, SJ
    Verbeek, JA
    Gundacker, H
    Sioufi, A
    Smith, IE
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (09) : 2338 - 2343
  • [9] Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer
    Ingle, JN
    Suman, VJ
    Johnson, PA
    Krook, JE
    Mailliard, JA
    Wheeler, RH
    Loprinzi, CL
    Perez, EA
    Jordan, VC
    Dowsett, M
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (07) : 1642 - 1649
  • [10] Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective
    Karnon, Jonathan
    Delea, Thomas
    Barghout, Vicki
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 9 (02): : 171 - 183
12345